Previous small studies have reported higher serum OPG levels in MS patients compared to healthy controls [22], and no difference in CSF OPG levels between patients with MS and patients with non-inflammatory neurological diseases [23]. Here, TNFRSF11B is linked to myeloid sarcoma.